Adding Immuron (IMRN) $2.57 to Superbug Watchlist.
CLICK FOR LIVE QUOTE
SUPER BUG STOCK REVIEW
Adding Todos Medical (TODMF) $0.03 to SuperBug Stock Review Watchlist.
Wall Street's War Against SuperBugs.
LIVE QUOTE
SuperBug Stock Review?...
Augmentative Wearable Device, Hapbee, Receives Amazing Reviews by Testers.
Originally posted on MartechSeries.
The innovative augmentative wearable device, Hapbee, has been giving testers a reason to be happy....
VirnetX (VHC) Scores $440 Million and Citius Pharma (CTXR) Sees Market Expand to Over...
Internet Stock Review
Blast from the past scores big!
We added VirnetX (VHC)...
Avenue Therapeutics (ATXI) Announces New Drug Application for IV Tramadol Accepted for Review by...
IV tramadol for the management of moderate to moderately severe pain in adults in a medically supervised health care setting.
Fortress Bio (FBIO) Inches Closer to $3.00 on Major News.
Fortress Bio (FBIO) Inches Closer to $3.00 on Major News.
Citius Pharma (CTXR) Inches Closer to the Next Phase...
Video: How Superbugs Get Started.
A World Health Organization (WHO) report released April 2014 stated, "this serious threat is no longer a prediction for the future, it is happening...
Citius (CTXR) Achieves 50% Patient Enrollment in Phase 3 Mino-Lok® Pivotal Trial
PHASE III PROGRESS
October 7th, 2019, Citius Completes 40% - Triggers Data Being Analyzed (is it working?).December 19th, 2019...
Okay, so What’s Next for Citius Pharma (CTXR) $1.16?
Dawson James Broker/Dealer Updates. Price Target Remains at $7.00.
"OK, So what’s Next? Topline data from the superior efficacy...
Citius Pharma (CTXR) $1.20. Price Target Upped to $4.00 at HC Wainright.
STREET INSIDER
H.C. Wainwright analyst Vernon Bernardino raised the price target on Citius Pharmaceuticals...
Latest article
Bavarian Nordic (BVNRY) Freeze Dries its MPOX Vaccine!
This is Big News, Honestly. We Are Adding to 2025 Watch List @ $7.36.
We last added Bavarian to...
Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.’s ‘Misinformation And Lies’ (IBD)
Sorting Through the Wreckage!
Full post on Investor's Business Daily.
Biotech stocks took a beating Monday...
Zomedica (ZOMDF) Surges 40% Higher, Friday.
Stock Surges 40%, After Management Conference Call to Calm the Natives.
Insider Buying Unleashed Today?
Not...
